✦ LIBER ✦

Three year clinical outcomes with zotarolimus (Endeavor) drug-eluting stents in an unrestricted contemporary practice

✍ Scribed by Giles, Katie; Hibbert, Benjamin; Drzymala, Luke; Armstrong, Marika; So, Derek; Le May, Michel R.; Glover, Christopher

Book ID: 122421851
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 187 KB
Volume: 168
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2013.01.234

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

194 Three year clinical outcomes associa

194 Three year clinical outcomes associated with the use of the zotarolimus-eluting stent in an unrestricted contemporary practice

✍ L. Drzymala; K. Giles; M. Armstrong; A. Ha; D. So; C. Glover 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 195 KB

Comparable Clinical Outcomes With Paclit

Comparable Clinical Outcomes With Paclitaxel- and Sirolimus-Eluting Stents in Unrestricted Contemporary Practice

✍ John Cosgrave; Gloria Melzi; Simon Corbett; Giuseppe G.L. Biondi-Zoccai; Pierfra 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 335 KB

Three-Year Clinical Outcome with the End

Three-Year Clinical Outcome with the Endeavor™ Zotarolimus-Eluting Stent in Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction: The Endeavor™ Primary PCI Study (E-PPCI)

✍ RHIDIAN J. SHELTON; KAMAL CHITKARA; RAVI SINGH; MICHA F. DORSCH; KATHRYN SOMERS; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Three-year clinical outcome in Type 2 di

Three-year clinical outcome in Type 2 diabetic patients with drug-eluting stents versus bare-metal stents with pioglitazone

✍ Kazuaki Nishio; Michio Hosaka; Meiei Shigemitsu; Youichi Kobayashi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

Sustained clinical safety and efficacy o

Sustained clinical safety and efficacy of a biodegradable-polymer coated sirolimus-eluting stent in “real-world” practice: Three-year outcomes of the CREATE (multi-center registry of EXCEL biodegradable polymer drug eluting stents) study

✍ Yaling Han; Quanmin Jing; Yi Li; Lixia Yang; Huiliang Liu; Xiaoming Shang; Tiemi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views